seroquel zoloft
For healthcare and medical correspondents SEROQUEL®: Further phase III trials to determine efficacy as a new treatment for devastating symptoms of bipolar disorder Alderley Park, UK.- 14 November, 2000 - AstraZeneca today announced the start of three phase III clinical trials to further determine the effectiveness of its atypical antipsychotic SEROQUEL (quetiapine) in the treatment of the symptoms of acute mania in patients with bipolar 1 disorder. The trials were prompted by recent encouraging data from existing trials which indicate that SEROQUEL is not only effective in alleviating psychotic symptoms, but also has beneficial effects on mood, aggression and hostility. heroin and zoloft zoloft online without a prescription zoloft for adhd zoloft and rash christian view on zoloft
